Clinical staging for cutaneous T cell lymphoma

S. I. Lamberg, S. B. Green, D. P. Byar, J. B. Block, W. E. Clendenning, M. C. Douglas, E. H. Epstein, Z. Y. Fuks, L. E. Golitz, A. L. Lorincz

Research output: Contribution to journalArticlepeer-review

Abstract

The Mycosis Fungoides Cooperative Group has been following patients with cutaneous T-cell lymphoma, including mycosis fungoides and the Sezary syndrome variant. Previous analyses identified the extent of skin involvement and the number of sites of clinically enlarged lymph nodes as important prognostic variables. These two variables were used to classify 340 patients into four clinical stages. Repeat analysis based on additional follow up data shows the usefulness of this clinical staging system for identifying patients with differing survival experience. An alternative grouping suggested by fitting a survival model to the data also has been studied. Staging systems based only on skin involvement and lymph nodes are recommended for general use because the information needed is readily available, requiring only physical examination.

Original languageEnglish (US)
Pages (from-to)187-192
Number of pages6
JournalAnnals of internal medicine
Volume100
Issue number2
DOIs
StatePublished - 1984

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint

Dive into the research topics of 'Clinical staging for cutaneous T cell lymphoma'. Together they form a unique fingerprint.

Cite this